Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Merck Secures U.S. Approval for ENFLONSIA Targeting Infant RSV
Tuesday, June 10, 2025Merck has received approval from the US Food and Drug Administration FDA for ENFLONSIA clesrovimabcforENFLONSIA is a longacting monoclonal antibody mAb developed to offer direct and lasting protection for up to five months which typically covers the...
Medicovestor and Sanyou Biopharmaceuticals Form Strategic Alliance to Advance Chemoimmunotherapy ADCs
Tuesday, June 10, 2025Medicovestor has entered into a strategic partnership with Sanyou BiopharmaceuticalsThe collaboration focuses on the development of innovative chemoimmunotherapy antibodydrug conjugates ADCs for cancer and autoimmune diseases
WuXi Biologics Begins Construction of Microbial Manufacturing Site for Commercial Production
Monday, June 09, 2025WuXi Biologics has commenced construction of a new microbial manufacturing site in Chengdus Wenjiang district a wellestablished centre for pharmaceutical development
Mission Bio Launches Single-Cell Multi-Omics Assay to Support Cancer Drug Development
Friday, June 06, 2025Mission Bio has introduced a new singlecell multiomics solution designed to improve clinical outcomes in cancer drug developmentThe companys latest innovation the SingleCell Genotype and Targeted Gene Expression assay enhances its Tapestri Platform b...
HUTCHMED and Innovent Announce NDA Acceptance in China for Fruquintinib–Sintilimab Combination in Advanced Renal Cell Carcinoma
Friday, June 06, 2025HUTCHMED and Innovent Biologics have jointly announced that the China National Medical Products Administration NMPA has accepted the New Drug Application NDA for the combination of fruquintinib and sintilimab
Elpis Biopharmaceuticals and Singapore General Hospital Collaborate to Advance Next-Generation Allogeneic CAR Technologies
Friday, June 06, 2025Elpis Biopharmaceuticals has entered into a research collaboration agreement with Singapore General Hospital SGHThe collaboration aims to develop advanced allogeneic CAR technologies including an armoured CART for acute myeloid leukaemia AML and a bi...
Bayer Receives Approval for Third Indication of Nubeqa™ in Advanced Prostate Cancer
Wednesday, June 04, 2025Bayer has received approval from the US Food and Drug Administration FDA for a new indication of its oral androgen receptor inhibitor Nubeqa darolutamide Prostate cancer is the second most common cancer and a leading cause of cancerrelated deaths amo...
Roche’s Evrysdi Tablet Gains European Commission Approval for Spinal Muscular Atrophy
Wednesday, June 04, 2025Roche has received approval from the European Commission for a new mg tablet formulation of Evrysdi risdiplam the first and only noninvasive diseasemodifying treatment for spinal muscular atrophy SMA
BioNTech and Bristol Myers Squibb Partner to Advance Bispecific Antibody BNT327 for Solid Tumours
Tuesday, June 03, 2025BioNTech and Bristol Myers Squibb have entered a global strategic agreement to jointly develop and commercialise BNT a nextgeneration bispecific antibody aimed at treating various solid tumours
ImmunityBio Granted FDA Expanded Access for ANKTIVA® to Treat Lymphopenia in Solid Tumour Patients
Tuesday, June 03, 2025ImmunityBio has received authorisation from the United States Food and Drug Administration FDA for Expanded Access to its Cancer BioShield platform The Cancer BioShield platform is an integrated immunotherapy strategy aimed at restoring immune functi...
